These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

191 related items for PubMed ID: 1385011

  • 1. Aprotinin and heparin monitoring during cardiopulmonary bypass.
    Hunt BJ, Segal H, Yacoub M.
    Circulation; 1992 Nov; 86(5 Suppl):II410-2. PubMed ID: 1385011
    [Abstract] [Full Text] [Related]

  • 2. [Effects of aprotinin on heparinized whole blood activated clotting time and whole blood prothrombin time].
    Wen Z, Zhu F, He X, Xiong S, He S.
    Hunan Yi Ke Da Xue Xue Bao; 1997 Nov; 22(4):304-6. PubMed ID: 9868081
    [Abstract] [Full Text] [Related]

  • 3. Increased anticoagulation during cardiopulmonary bypass by aprotinin.
    de Smet AA, Joen MC, van Oeveren W, Roozendaal KJ, Harder MP, Eijsman L, Wildevuur CR.
    J Thorac Cardiovasc Surg; 1990 Oct; 100(4):520-7. PubMed ID: 1699088
    [Abstract] [Full Text] [Related]

  • 4. Celite and kaolin produce differing activated clotting times during cardiopulmonary bypass under aprotinin therapy.
    Feindt P, Seyfert UT, Volkmer I, Straub U, Gams E.
    Thorac Cardiovasc Surg; 1994 Aug; 42(4):218-21. PubMed ID: 7529949
    [Abstract] [Full Text] [Related]

  • 5. The effect of aprotinin on the response of the activated partial thromboplastin time (APTT) to heparin.
    Francis JL, Howard C.
    Blood Coagul Fibrinolysis; 1993 Feb; 4(1):35-40. PubMed ID: 7681330
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Monitoring activated clotting time for combined heparin and aprotinin application: in vivo evaluation of a new aprotinin-insensitive test using Sonoclot.
    Ganter MT, Monn A, Tavakoli R, Genoni M, Klaghofer R, Furrer L, Honegger H, Hofer CK.
    Eur J Cardiothorac Surg; 2006 Aug; 30(2):278-84. PubMed ID: 16828293
    [Abstract] [Full Text] [Related]

  • 9. Activated coagulation and activated partial thromboplastin times in assessment and reversal of heparin-induced anticoagulation for cardiopulmonary bypass.
    Dauchot PJ, Berzina-Moettus L, Rabinovitch A, Ankeney JL.
    Anesth Analg; 1983 Aug; 62(8):710-9. PubMed ID: 6869857
    [Abstract] [Full Text] [Related]

  • 10. The effects of MDCO-2010, a serine protease inhibitor, on activated clotting time in blood obtained from volunteers and cardiac surgical patients.
    Kim H, Szlam F, Tanaka KA, van de Locht A, Ogawa S, Levy JH.
    Anesth Analg; 2012 Aug; 115(2):244-52. PubMed ID: 22584552
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Effect of aprotinin on activated clotting time, whole blood and plasma heparin measurements.
    Despotis GJ, Joist JH, Joiner-Maier D, Alsoufiev AL, Triantafillou AN, Goodnough LT, Santoro SA, Lappas DG.
    Ann Thorac Surg; 1995 Jan; 59(1):106-11. PubMed ID: 7529483
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Monitoring of r-hirudin anticoagulation during cardiopulmonary bypass--assessment of the whole blood ecarin clotting time.
    Pötzsch B, Madlener K, Seelig C, Riess CF, Greinacher A, Müller-Berghaus G.
    Thromb Haemost; 1997 May; 77(5):920-5. PubMed ID: 9184403
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. The prolonged activated clotting time (ACT) with aprotinin depends on the type of activator used for measurement.
    Wendel HP, Heller W, Gallimore MJ, Bantel H, Müller-Beissenhirtz H, Hoffmeister HE.
    Blood Coagul Fibrinolysis; 1993 Feb; 4(1):41-5. PubMed ID: 7681331
    [Abstract] [Full Text] [Related]

  • 19. In vitro effects of aprotinin on activated clotting time measured with different activators.
    Wang JS, Lin CY, Hung WT, Thisted RA, Karp RB.
    J Thorac Cardiovasc Surg; 1992 Oct; 104(4):1135-40. PubMed ID: 1383640
    [Abstract] [Full Text] [Related]

  • 20. Elevated activated partial thromboplastin time does not correlate with heparin rebound following cardiac surgery.
    Taneja R, Marwaha G, Sinha P, Quantz M, Stitt L, Gao R, Subramanian S, Schaus M, Keeney M, Chin-Yee I, Murkin J.
    Can J Anaesth; 2009 Jul; 56(7):489-96. PubMed ID: 19408066
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.